Newsroom

For media inquiries, please contact 340B Health Senior VP of Communications Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.

• STATEMENT BY 340B HEALTH INTERIM PRESIDENT AND CEO MAUREEN TESTONI ON FINAL RULE TO ENFORCE DRUG INDUSTRY TRANSPARENCY

  November 29, 2018 in 340B Health News Releases

• 340B HEALTH URGES END TO DELAYS IN POLICING DRUGMAKER OVERCHARGES

  November 20, 2018 in 340B Health News Releases

• Statement By 340B Health Interim President and CEO Maureen Testoni on Final Medicare Rule Cutting Payments to 340B Hospitals

  November 02, 2018 in 340B Health News Releases

• STATEMENT BY 340B HEALTH INTERIM PRESIDENT AND CEO MAUREEN TESTONI REGARDING PROPOSAL TO ENFORCE DRUG INDUSTRY TRANSPARENCY RULES

  October 31, 2018 in 340B Health News Releases

• Statement By 340B Health Interim President and CEO Maureen Testoni on President Trump’s Proposed International Pricing Index Model

  October 26, 2018 in 340B Health News Releases

• Hundreds of Hospital CEOs Call on Congressional Leaders to Protect 340B

  October 02, 2018 in 340B Health News Releases

• Statement By 340B Health Interim President and CEO Maureen Testoni on AHA’s 340B Program Stewardship Principles

  September 18, 2018 in 340B Health News Releases

• Hospital Groups File Lawsuit to Shine Needed Light on Drug Company Pricing and Overcharging

  September 11, 2018 in 340B Health News Releases

• 340B HEALTH STATEMENT ON CMS PROPOSED 2019 OPPS RULE

  July 25, 2018 in 340B Health News Releases

• OP-ED: AT JPS HEALTH IN TEXAS, 340B SAVINGS GO “DIRECTLY TO INCREASING ACCESS FOR MORE PATIENTS

  July 25, 2018 in 340B in the News

• PROTECT 340B PROGRAM, HOSPITAL GROUPS URGE ADMINISTRATION IN COMMENTS ON DRUG PRICING BLUEPRINT

  July 18, 2018 in 340B in the News

• 340B HEALTH URGES ADMINISTRATION TO SUPPORT THE 340B DRUG DISCOUNT PROGRAM

  July 16, 2018 in 340B Health News Releases